Herbal 
INTRODUCTION
Malaria has been a threat to humans for many years. Despite the many advances in both preventive and curative treatments in the zo-Century, malaria is still a major killer today, and deaths from the disease have increased in the past three decades.!" There are 350 to 500 million clinical episodes of malaria each year. It causes over 1 million deaths and is the eighth most important disease in terms of lost disability-adjusted life years.F'
Indigenous plants play an important role in the treatment of a variety of diseases. About 80% of the population in many developing countries including Ghana, depend on plants as accessible, first line, and cost-effective therapy for malaria. However, many of these plants have not been systematically investigated as anti-malarials. Among the • many species of plants employed in malaria rernediesl'l in Ghana are Adenia cisssmpcloides (Planch.) Harms, Termine haivorensis A. Chev:, and Elaeis guineensis Jacq,f4) A. cissampeloidesis a climber. Other common uses of the plant include the treatment of dysentery, rheumatic pain relief,fS)hypertension, and numbness.l'" T. ivorensis is appreciated mainly for its timber. However,the stem bark is also employed in wound healing and as a remedy for rheumatism.F' Other folklore uses of E. guineensis include treatment of gonorrhea, headache, rheumatism diuretic and an aphrodisiac'f and wound healing. 1 9 ,10) The dried leaves have been reported to possess hemos ta tic properties. [l1J This study, therefore, seeks to verify the anti-plasmodial properties of these plants in order to justify their use in malaria remedies. 
MATERIALS AND METHODS

Collection of plant materials
Plasmodium talclparum culture and maintenance
In vitro anti-plasmodial activity of the plant extracts were assessed at the Immunology Department of the Noguchi Memorial Institute for Medical Research, Legon, Ghana. Plasmodium parasites were grown and maintained in culture using the Trager and Jensen method with some modifications'F' using P falciparum chloroquine resistant strain, 3D7. The parasites were maintained in vitro in human O-positive red blood cells using RPMI 1640 medium supplemented with 25mM HEPES and 25Mm NaHC0 3 and were complemented with 2% human O-positive serum and 10 mg/ml Gentamycin. The cultures were gassed with 5.5% CO 2 , 2% 02' and 92.5% N 2 , and incubated at 37°C. Culture flask with 3D7 parasite strains was maintained by the daily change of culture media and preparation of thin RBC smears to monitor parasite groWd1.
Preparation of sterile extracts
A stock solution of 100 J.tg/ml was prepared from the crude ethanolic extract of each plant material and filtered with millipore filter of size 0.2 J.tg (Carrigtwohill, Ireland) under sterile conditions. Four-fold serial dilutions were prepared from each stock solution using Complete Parasite Medium, resulting in concentrations ranging from 100 -0.0976562J.tg/ ml. Artesunate (Sigma-Aldrich, USA; 98% purity), a known standard anti-malarial drug, was used
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• as a positive control.
Establishment of anti-plasmodia! activities of extracts
The in vitro inhibition assay used was a modification of the semi-automatic micro dilution technique developed by Desjardins et al.l 13 ] The cultures were treated with the selected concentrations of the extracts in two 24-well micro titre plates (Greiner Bio-One, Belgium) and incubated for 72 hours at 37°C. Thin blood smears were prepared on properly labeled slides. The blood smears were air-dried and fixed in methanol. The dried slides were Giemsa stained and observed with 100x microscopic lens in immersion oil using a light microscope.
Statistical analysis of data Growth inhibition due to each extract defined as the difference between the % parasitemia of each treatment group, and the corresponding positive control was calculated as follows: [14] % Growth inhibition = (0/0 Parasitemia CIRBC -% parasitemia DIRBC) x 100% % parasitemia C1RBC
Where CIRBC = % parasitemia of infected RBC without extracts i.e. control DIRBC = % parasitemia of infected RBCs incubated with extract or standard drug Total parasitemia over the 48 hour period was calculated in arbitrary unit as the area under the curve (AUC). Differences in AUCs were analyzed by one-way analysis of variance (ANOVA) followed by Student-Newman-Keuls' post hoc t test.
Doses and concentrations
responsible for 50% of the maximal effect (ICsJ for each drug/ extract were determined using an iterative computer least squares method, with the following non-linear regression (three-parameter logistic) equation.
y = -:--a_+_("-b_---'a ):.....--,-(1+1O(LogICSO-X))
Where, X is the logarithm of dose and Y is the response. 
RESULTS
The phytochemical analysis of the extracts revealed the presence of some secondary metabolites as elaborated in Table 2 .
DISCUSSION
••
Malaria still poses as a major health problem in the developing world. Itis the number one cause of morbidity, accounting for over 40% of outpatient attendance in public health facilities.F" Pregnant women and children are the most vulnerable to the disease.I'f When malaria is not properly treated in pregnant women, it can cause anemia and can also lead to miscarriages, stillbirths, underweight babies, and maternal death.I'I' Malaria is caused by the unicellular protozoan of the genus Plasmodium. Four species are infectious to man, with P falciparum being the deadliest''?' and accounts for up to 80% of all malaria cases in the world.F" In many parts of the world, the parasites have developed resistance to a number of anti-malarials such as chloroquine, sulphadoxine-pyrimethamine, and other conventional drugs.F" Resistance to these drugs has been reported to be as high as 40 to 60% in some African and Asian countries.F'' Further studies indicate that resistance to chloroquine, which was the most widely used treatment for malaria, may be responsible for the increase in malaria-specific mortality in many malariaendemic countries.F'<" There is, therefore, an urgent need to discover new compounds with different modes of action. However, the use of plant-derived drugs for the treatment of malaria has a long and successful tradition. For example, quinine isolated from Cinchona succirubra and artemisinin from Artemisia annua illustrate the potential value of investigating traditionally used malaria herbal remedies for anti-malarial drugs or lead compounds for drug development agenda.
[2S]
The present study assessed the anti-plasmodial activity of A. cissampeloides, T ivorensis, and E. guineensis. E. guineensis exhibited the highest activity with an I C so value 1.19 5~g/ ml. This was followed T ivorensis (IC so 6.949~g/ ml) and A. cissampeloides showed the least activity (IC so 8.521~g/ ml). However, artesunate, a known anti-malarial used as a positive control in this experiment, exhibited a much higher activity (IC so 0.031~g/ml) than the plant extracts under. According to Zofou et aI., [26] , an anti-plasmodial agent is very active when its IC so value is less than 10~g/ml, moderately active when its IC so falls between 10 and 25~g/ ml, weakly active when its IC so falls between 25 and 50~g/ ml, and very weakly active when the IC so exceeds 50~g/ml. This indicates that all 3 plants were highly active against P falciparum.
Different
classes of compounds in plants such as alkaloids [27] , quassinoids, sesquiterpene lactones+", and flavonoids [28] have been found to exhibit anti-plasmodial activity through several mechanisms. For instance, some alkaloids exhibit their action by binding with the haem within the erythrocytes, thus preventing its detoxification into its polymeric form (hemozoin) and thus preventing consumption by the parasite,129,30] while some flavonoids have also been known to chelate metals such as iron and copper as part of their antioxidant effects and that iron chelating therapies have been recommended for malaria patients.F'' Further studies to determine the stage-specific anti-plasmodial activities of the alkaloids and flavonoids from our plant samples are on-going in our laboratories.
